Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Regeneron Pharmaceuticals Inc., 3 years.
Regeneron Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | Regeneron Pharmaceuticals Inc. | Option exercise | +800 | $376.69 | $301,352 |
| Aug 10, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −800 | $800.00 | $640,000 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Option exercise | +1,638 | $376.69 | $617,018 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −49 | $774.68 | $37,959 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −50 | $775.50 | $38,775 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −53 | $778.47 | $41,259 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −208 | $779.55 | $162,146 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −331 | $780.45 | $258,329 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −209 | $781.28 | $163,288 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −298 | $782.10 | $233,066 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −220 | $783.29 | $172,324 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −160 | $784.45 | $125,512 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −56 | $785.61 | $43,994 |
| Feb 19, 2026 | Regeneron Pharmaceuticals Inc. | Open-market sale | −4 | $790.00 | $3,160 |
| Jan 2, 2026 | Regeneron Pharmaceuticals Inc. | Grant or award | +155 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.